Bank of America Corp. (BAC) made a modest gain of 0.98% on Friday, reaching $30.96 per share. This positive movement occurred during a successful trading session for the stock market as a whole. The S&P 500 Index (SPX) rose 0.41% to reach 4,604.37, while the Dow Jones Industrial Average (DJIA) saw a gain of 0.36% to reach 36,247.87.

Continuous Growth

This marks the second consecutive day of gains for Bank of America Corp., showing a promising trend for the company. However, the stock is still $6.04 below its 52-week high of $37.00, which was achieved on February 7th.

Comparison to Competitors

In comparison to some of its competitors on that day, Bank of America's stock performance was relatively underwhelming. JPMorgan Chase & Co. (JPM) experienced a stronger increase of 1.10%, reaching $158.52 per share, while Wells Fargo & Co. (WFC) saw an even greater rise of 1.54%, reaching $46.10 per share.

Trading Volume

The trading volume for Bank of America Corp. was 34.6 million shares, which falls 13.5 million shares below its 50-day average volume of 48.1 million shares.


Thailand Shares Close Flat

Donald Trump Chooses Not to Testify for Second Time in New York Civil Fraud Trial

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Apple Stock Showing Signs of Recovery
News

Apple Stock Showing Signs of Recovery

Apple stock is making a comeback after a sharp decline, with support levels and indicators signaling a positive outlook.

Stadler Rail Reports Strong Performance in First Half
News

Stadler Rail Reports Strong Performance in First Half

Shares of Stadler Rail surge after strong performance with increased free cash flow and solid order intake.

Oil Prices Continue to Rise as Supply Tightens and Demand Remains Steady
News

Oil Prices Continue to Rise as Supply Tightens and Demand Remains Steady

Oil prices are surging due to voluntary output cuts by Russia and Saudi Arabia, potentially reaching $100 per barrel. Th...

Galenica Reports Increased Sales for 2023
News

Galenica Reports Increased Sales for 2023

Swiss pharmaceutical company Galenica confirms its earnings outlook for 2023 after experiencing increased sales across a...